乌鸦传媒

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates

Randomized trial "highly encouraging" for making patients feel and function better

Either choice is "acceptable" based on randomized study

ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent

Eight decades after FDR's decline and death, do White House physicians owe truth to the public?

Three regimens compared head-to-head among abundant choices

Most cases were mild, and age was a predictor of disease

Question of clinical benefit beyond LVEF improvement will require larger trials

The amino acid mixture reduced stage 3 AKI by 44% compared with placebo

New additions to Sapien, Evolut, Navitor lines aim to ensure coronary access

Having the technology reach the right patients is a major challenge in the real world

Current transcatheter mitral valve replacement devices a poor match for clinical need

Rising mortality burden from high ambient temperatures around the world